BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.
about
Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor ImmunityTargeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory diseaseProduction of TGF-beta1 as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF.Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switchingThe transforming growth factor-betas. A new family of immunoregulatory molecules.Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type betaTransforming growth factor-beta in disease: the dark side of tissue repair.Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesionsTransforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animalsExpression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.Systemic immunological effects of cytokine genes injected into skeletal muscle.Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytesInhibition of cytokine production by cyclosporin A and transforming growth factor beta.TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis.Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in miceImmunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glandsProtective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity.Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines.Transcriptional regulation of the transforming growth factor-beta2 gene in glioblastoma cells.Role of transforming growth factor beta (TGF beta) in systemic autoimmunity.Inhibition by methylprednisolone acetate suggests an indirect mechanism for TGF-B induced angiogenesis.The regulatory role of transforming growth factor-beta in activation of milk mononuclear cells.Growth regulatory effects of transforming growth factor-beta 1 and interleukin-2 on IL-2 dependent CD4+T lymphoblastoid cell line.Isolation of two new proteins from bovine colostrum which stimulate epidermal growth factor-dependent colony formation of NRK-49F cells.Inhibition of Nb2 T-lymphoma cell growth by transforming growth factor-betaModulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery.Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.Suppression of anti-tumor CD4+ T cell responsiveness in the tumor-bearing state and its recovery in in vitro culture free of tumor burden.Improvement of macrophage dysfunction by administration of anti-transforming growth factor-beta antibody in EL4-bearing hosts.
P2860
Q28075996-A4824327-DE0E-42BE-A9A8-CC9A94C6F70DQ28202655-07143C28-BD56-4D48-A01C-3AAF31F2BEBBQ33578067-E6162F43-DA92-41FA-829F-C0CFBE578512Q33594738-4F4462BE-0230-4B5D-A181-1F142AA5C8F2Q34042442-D5251E1E-39D0-4DC8-A3F8-4ACD5CB12700Q34627626-E615337B-CFD8-4479-BFA7-205930D4ED41Q35603155-C716C773-3F82-4A8B-9DEA-843500CB6F79Q35607475-7CACB73D-ECEA-4D38-BA35-90A37FCFC2BCQ35820693-E3BA591D-5287-42D0-8E4D-62AD0BEC4157Q36133581-DE6D20A8-D2F5-4166-93F5-21AF7B3EEEFAQ36302958-8D64D4FB-FA4F-41F7-AB60-0C4851C2BCDFQ36353974-ED1CCCDE-7C44-40BC-81DD-55C26CC37317Q36356779-06DA4BC9-78FE-440B-83A9-E07FEF9E696CQ36357285-5FD01BED-E5D8-44E0-B4A5-09D40BAD63ACQ36733587-A765ACC2-DDF9-4D44-A5D8-315A87E32BFFQ37147228-244F285B-76E4-4366-B116-558A55831E7FQ37222690-1A7C9F33-9C72-487A-BD96-FACAD057182EQ37468752-27E79AAB-329E-4E78-9459-44F0DE3EA797Q38824306-897ACBA2-BDA7-4492-BE0E-D7C8F1ADDCA5Q39631154-DC8BB363-4C9E-40AA-A733-B213B7EA60DAQ40671444-EEC21200-0B98-495F-86B0-5B22231C6AE9Q40759126-1D96E9A0-54A7-416A-A756-76999E58D41DQ40794752-0246F105-AE31-4A9E-9B5E-1F4ABA3F9C2EQ41092542-75CC526E-5AC2-48E7-B7C1-9B21BD26AABCQ41096744-EFC3AFED-8B86-4E9C-B156-FA227FAB5E04Q41252562-BCED7A6B-1C19-485B-A24C-FFB3742F79E6Q41751931-B82DAC6D-0795-4914-AAC7-AA167114AD1FQ41791256-6E0CD77A-9701-4464-8418-BB0E40755017Q45875458-E9C07F74-3241-4AE0-B949-B4E07A91AF44Q55145161-00AEB421-C48A-4CA2-8175-56E7FAF49EF2Q55231913-6902E01C-193C-4428-8DB7-D11F572869E5Q55263243-5E15BA10-2762-4FF6-BB76-9F0B91CC6E7F
P2860
BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BSC-1 growth inhibitor/type be ...... or of thymocyte proliferation.
@en
BSC-1 growth inhibitor/type be ...... or of thymocyte proliferation.
@nl
type
label
BSC-1 growth inhibitor/type be ...... or of thymocyte proliferation.
@en
BSC-1 growth inhibitor/type be ...... or of thymocyte proliferation.
@nl
prefLabel
BSC-1 growth inhibitor/type be ...... or of thymocyte proliferation.
@en
BSC-1 growth inhibitor/type be ...... or of thymocyte proliferation.
@nl
P2860
P356
P1476
BSC-1 growth inhibitor/type be ...... or of thymocyte proliferation.
@en
P2093
P2860
P304
P356
10.1073/PNAS.83.15.5531
P407
P577
1986-08-01T00:00:00Z